CD4 and neoplasm: In this study, we stained pretherapeutic biopsy samples with immunohistochemistry (CD4 and CD8) and examined intratumoral periglandular lymphocytes (IPLs) and TILs in relation to post-treatment tumor regression grade (TRG).